Centerpoint Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$355K Buy
1,081
+1
+0.1% +$312 0.1% 72
2026
Q2
$468K Hold
1,080
– – 0.13% 58
2026
Q1
$231K Hold
1,080
– – 0.08% 79
2025
Q4
$185K Sell
1,080
-7
-0.6% -$1.09K 0.06% 87
2025
Q3
$146K Buy
1,087
+80
+8% +$8.47K 0.05% 106
2025
Q2
$98K Buy
1,007
+7
+0.7% +$555 0.03% 118
2025
Q1
$73K Hold
1,000
– – 0.03% 138
2024
Q4
$72K Hold
1,000
– – 0.03% 148
2024
Q3
$82K Hold
1,000
– – 0.03% 137
2024
Q2
$106K Hold
1,000
– – 0.04% 127
2024
Q1
$97K Hold
1,000
– – 0.04% 128
2023
Q4
$78K Sell
1,000
-170
-15% -$11.6K 0.03% 130
2023
Q3
$73K Hold
1,170
– – 0.03% 135
2023
Q2
$75K Hold
1,170
– – 0.03% 138
2023
Q1
$62K Buy
1,170
+30
+3% +$1.47K 0.03% 142
2022
Q4
$48K Hold
1,140
– – 0.02% 143
2022
Q3
$42K Buy
1,140
+1,000
+714% +$44.5K 0.02% 140
2022
Q2
$6K Hold
140
– – ﹤0.01% 258
2022
Q1
$7K Hold
140
– – ﹤0.01% 250
2021
Q4
$10K Buy
+140
New +$8.78K ﹤0.01% 222

Other funds holding LRCX

Centerpoint Advisors's LRCX Position: Q3 2026 in Review

Centerpoint Advisors increased its Lam Research (LRCX) stake by 0.09% in Q3 2026, buying an estimated $312 and bringing the position to 1,081 shares worth $355K. The position accounts for 0.1% of the portfolio, ranked #72.

Centerpoint Advisors first reported a position in LRCX in Q4 2021 and has held it in 20 quarters since. The position peaked at $468K in Q2 2026. 1,804 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Centerpoint Advisors held 1,081 shares of Lam Research worth $355K as of Q3 2026.
  • Centerpoint Advisors bought 1 Lam Research share in Q3 2026, an estimated $312.
  • Lam Research made up 0.1% of Centerpoint Advisors's portfolio in Q3 2026, its #72 holding.
  • Centerpoint Advisors first reported a position in Lam Research in Q4 2021 and has held it in 20 quarters since.
  • Centerpoint Advisors's Lam Research position peaked at $468K in Q2 2026.
  • 1,804 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.